Evaluation of a new rapid anti-HbF FITC assay, Trillium QuikQuant, for detection and quantitation of foetomaternal haemorrhage

International Journal of Laboratory Hematology

Volumn 35, Issue 1, 2013, Pages 106-110

  Fong, E A ^a   Finlayson, J ^a   Robins, F ^a   Davies, J ^a   Joseph, J ^a   Rossi, E ^a   Grey, D E ^a  

^a PATHWEST LABORATORY MEDICINE   (Australia)

Author keywords

Anti HbF FITC; Flow cytometry; Foetomaternal haemorrhage; Trillium QuikQuant

Indexed keywords

FLUORESCEIN ISOTHIOCYANATE; HEMOGLOBIN F;

ARTICLE; BLOOD GROUP RHESUS SYSTEM; BLOOD SAMPLING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC KIT; ERYTHROCYTE; FEMALE; FETOMATERNAL TRANSFUSION; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PUERPERIUM; RHESUS IMMUNIZATION; UMBILICAL CORD BLOOD;

ADULT; FEMALE; FETAL HEMOGLOBIN; FETOMATERNAL TRANSFUSION; FLOW CYTOMETRY; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENT DYES; HUMANS; INFANT, NEWBORN; MALE; POSTPARTUM PERIOD; PREGNANCY; PRENATAL DIAGNOSIS; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; RH-HR BLOOD-GROUP SYSTEM; STATISTICS AS TOPIC; TIME FACTORS;

EID: 84872268786     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/j.1751-553X.2012.01463.x     Document Type: Article

References (15)

1. Australian and New Zealand Society of Blood Transfusion (ANZSBT). Guidelines for laboratory assessment of fetomaternal haemorrhage, 2002. http://www.anzsbt.org.au/publications/documents/ANZSBTguide_Nov02a.pdf (accessed February 2012)
2. Jakobovicz R, Williams L, Silberman F. Immunisation of Rh-negative volunteers by repeated injections of very small amounts of Rh-positive blood. Vox Sang 1972;23:376-81.
3. Kleihauer E, Braun H, Betke K. Demonstration of fetal haemoglobin in erythrocytes of a blood smear. Klin Wochenschr 1957;35:637-8.
4. Bowman JM, Pollock JM, Penston E. Fetomaternal transplacental hemorrhage during pregnancy and after delivery. Vox Sang 1986;51:117-21.
5. Augustson BM, Fong EA, Grey DE, Davies JI, Erber W. Postpartum anti-D: can we safely reduce the dose? Med J Aust 2006;184:611-3.
6. Huchet J, Defossez Y, Brossard Y. Detection of transplacental hemorrhage during the last trimester. Transfusion 1988;28:506.
7. Lloyd-Evans P, Guest AR, Voak D, Scott ML. Detection of weak D and DVI red cells in D-negative mixtures by flow cytometry: implications for feto-maternal haemorrhage quantification and D typing policies for newborns. Br J Haematol 1999;101:621-5.
8. Flegal WA, Khull SR, Wagner FF. Primary anti-D immunisation by weak D type2 RBCs. Transfusion 2000;40:428-34.
9. Gorick B, McDougall DC, Ouwehand WH, Overbeeke MA, Tippett P, Hughes-Jones NC, van Rhenen DJ. Quantitation of D sites on selected 'weak D' and 'partial D' red cells. Vox Sang 1993;65:136-40.
10. Kennedy GA, Shaw R, Just S, Bryson G, Battistutta F, Rowell J, Williams B. Quantification of fetomaternal haemorrhage (FMH) by flow cytometry: anti-fetal haemoglobin labelling potentially underestimates massive FMH in comparison to labelling with anti-D. Trans Med 2003;13:25-33.
11. Davis BH, Olsen S, Bigelow NC, Chen JC. Detection of fetal red cells in fetomaternal hemorrhage using a fetal haemoglobin monoclonal antibody by flow cytometry. Transfusion 1998;38:749-56.
12. Popat N, Wood WG, Weaterall DJ, Turnbull AC. Pattern of maternal F-cell production during pregnancy. Lancet 1977;2:377-9.
13. Nelson M, Popp H, Horky K. Development of a flow cytometric test for the detection of D-positive fetal cells after fetomaternal hemorrhage and a survey of the prevalence in D-negative women. Immunohematology 1994;10:55-9.
14. Italia KY, Colah R, Mohanty D. Evaluation of F cells in sickle cell disorders by flow cytometry - comparison with the Kleihauer-Betke's slide method. Int J Lab Hematol 2007;29:409-14.
15. Leers MP, Pelikan HM, Salemans TH, Giordano PC, Scharnhorst V. Discriminating fetomaternal hemorrhage from maternal HbF-containing erythrocytes by dual-parameter flow cytometry. Eur J Obstet Gynecol Reprod Biol 2007;134:127-9.